GE, Intel Form Home Health Technology Alliance To Boost Sales, R&D
GE and Intel will invest $250 million over the next five years to develop home-based health technologies for seniors and chronically-ill patients, the firms announced April 2
More from Archive
More from Medtech Insight
• By
The deadline for comments is 30 June 2025
• By
Dexcom announced it received US clearance for its 15-day CGM, which has a MARD of 8.0% and is expected to launch in the second half of 2025 to allow for integration with insulin pumps.
• By
Biotech and pharma are increasingly clear about one thing: They need diagnostics. But with prices suppressed, how have diagnostics companies proven their utility without going under?